Cyclacel Pharmaceuticals, Inc. Balance Sheet

Balance Sheet FYE: 31-Dec

Assets9/30/20086/30/20083/31/200812/31/2007
Cash & Short Term Investments33.7239.9748.9858.75
Receivables - Total1.64NA3.152.47
Inventories - Total0.570.610.350.21
Total Current Assets37.3145.8154.3163.78
Net Property, Plant & Equipment2.292.782.953.02
Total Assets41.6357.2266.1275.91
Liabilities    
Accounts Payable8.369.178.818.64
Debt in Current Liabilities0.59NANANA
Total Current Liabilities9.8811.6211.1814.71
Long-Term Debt0.62NA1.16NA
Total Liabilities11.8513.8114.1817.94
Stockholder's Equity    
Minority InterestNANANANA
Preferred Stock0.000.000.000.00
Common Stock0.020.020.020.02
Retained Earnings-194.77-177.13-168.58-162.33
Treasury StockNANANANA
Total Stockholders' Equity29.7743.4151.9457.97
Total Liabilities and Stockholders' Equity41.6357.2266.1275.91

Cyclacel Pharmaceuticals, Inc. Balance Sheet


RYZONE FINANCIAL

BUSINESS
FUNDAMENTAL DATA